[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Novo-Nordisk (NVO)
Novo Nordisk is cutting 9000 jobs globally due to rising competition and lowered profit outlook, but the company's oral Wegovy pill showed significant weight loss in a new study.
About Novo-Nordisk
Novo Nordisk (NVO) is a pharmaceutical company specializing in diabetes and obesity treatments.
Novo-Nordisk uses the ticker $NVO for trading. Listed in the Stocks and category within the Healthcare sectors.
Insights #
- Novo-Nordisk (NVO) sentiment is up XXXXX% from the previous week.
Price: $XXXXX #
Price 24-Hour Time-Series Raw Data
The price action is likely influenced by a combination of factors. The positive clinical trial results and Wegovy's cardiovascular benefits are likely supporting the price, while the lowered sales outlook and increased competition are likely putting downward pressure on the stock.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| -XXX% | -XXXX% | -XXXX% |
1-Year High: $XXXXXX on 2024-10-17
1-Year Low: $XXXXX on 2025-08-06
AltRank: XXXXX #
AltRank 24-Hour Time-Series Raw Data
Novo-Nordisk (NVO) is currently AltRank #1,374 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXX +90
1 Month: XXXXX +1,313
6 Months: XXXXX -X
1 Year: XXXXX +1,034
1-Year High: XXXXX on 2025-07-17
1-Year Low: X on 2025-06-10
Galaxy Score: XX #
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Week: XX +2
1 Month: XX -XX
6 Months: XX -XX
1 Year: XX +18
1-Year High: XX on 2025-06-10
1-Year Low: XX on 2025-01-03
Engagements: XXXXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXXX
Daily Average: XXXXXXX
1 Week: XXXXXXXXX -XX%
1 Month: XXXXXXXXXX +50%
6 Months: XXXXXXXXXXX +210%
1 Year: XXXXXXXXXXX +247%
1-Year High: XXXXXXXXX on 2025-06-23
1-Year Low: XXXXXX on 2024-10-16
| Social Network | X | TikTok | YouTube | |
|---|---|---|---|---|
| Engagements | XXXXXXX | XXXXXX | XXXXX | X |
Mentions: XXXXX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
1 Month: XXXXX -XX%
6 Months: XXXXXX +88%
1 Year: XXXXXX +100%
1-Year High: XXXXX on 2025-06-25
1-Year Low: XXX on 2024-10-18
| Social Network | X | TikTok | YouTube | |
|---|---|---|---|---|
| Mentions | XXXXX | XXX | XX | X |
Creators: XXX #
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning Novo-Nordisk (NVO) in the last XX hours which is up XXXX% from XXX in the previous XX hours
Daily Average: XXX
1 Month: XXXXX -XX%
6 Months: XXXXXX +85%
1 Year: XXXXXX +129%
1-Year High: XXXXX on 2025-06-25
1-Year Low: XXX on 2024-10-18
The most influential creators that mention Novo-Nordisk in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @novonordisk | X | XXXXXX | XX | XXXXXX |
| @TheLongInvest | X | XXXXXXX | X | XXXXXX |
| @TacticzH | X | XXXXXX | XX | XXXXXX |
| @MMatters22596 | X | XXXXXX | XX | XXXXXX |
| @meeijer | X | XXXXXX | XX | XXXXXX |
| @BourbonCap | X | XXXXXX | X | XXXXXX |
| @bioinvestor24 | X | XXXXX | XX | XXXXX |
| @investseekers | X | XXXXX | XX | XXXXX |
| @KNielsen2000 | X | XXXXX | XX | XXXXX |
| @danielisdizzy | XX | XXXXXX | X | XXXXX |
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% +23%
1 Month: XX% +14%
6 Months: XX% +6%
1 Year: XX% +12%
1-Year High: XX% on 2024-11-03
1-Year Low: XX% on 2025-05-31
Most Supportive Themes
- Positive Clinical Trial Results and Wegovy's Cardiovascular Benefits: (35%) Posts highlighting positive results from clinical trials for Novo Nordisk's drugs, particularly Wegovy, and its cardiovascular benefits.
- Long-Term Growth Potential and Valuation: (25%) Posts discussing the long-term growth potential of Novo Nordisk, especially in the obesity and diabetes markets, and its current valuation.
- Expert Analysis and Recommendations: (15%) Posts from analysts and financial experts recommending Novo Nordisk as a buy or highlighting its strengths.
Most Critical Themes
- Competition and Market Share Concerns: (20%) Posts expressing concerns about increasing competition from other pharmaceutical companies, particularly Eli Lilly, and its impact on Novo Nordisk's market share.
- Negative Guidance and Restructuring: (5%) Posts discussing the company's lowered sales and operating profit outlook, job cuts, and restructuring efforts.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXXX | XX% | XXXXXXX | XX% | XXXXXX | XX% |
| TikTok | XXXXX | X% | XXXXXX | XX% | XXXXXX | X% |
| YouTube | XXX | X% | XXXXX | X% | XX | X% |
| X | X% | X | X% | X | X% | |
| Total | XXXXXX | XX% | XXXXXXX | XX% | XXXXXX | XX% |
Social Dominance: XXXXX% #
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
1 Week: XXXXX% -XXXXX%
1 Month: XXXXX% +0.201%
6 Months: XXXXX% +0.023%
1 Year: XXXXX% +0.124%
1-Year High: XXXXX% on 2025-06-25
1-Year Low: XXXXX% on 2025-07-26
Market Dominance: XXXXX% #
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXXX% on 2025-08-06
Market Cap: $XXXXXXXXXXXXXXX #
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXXXX -$6.20%
1 Month: $XXXXXXXXXXXXXXX +$1.80%
6 Months: $XXXXXXXXXXXXXXX -$3.70%
1 Year: $XXXXXXXXXXXXXXX -$53%
1-Year High: $XXXXXXXXXXXXXXX on 2024-10-17
1-Year Low: $XXXXXXXXXXXXXXX on 2025-08-06
Top assets mentioned In the posts about Novo-Nordisk in the last XX hours
Eli Lilly and Company (LLY) UnitedHealth Group (UNH) Eli Lilly and Company (LLY) Hims & Hers Health, Inc. (HIMS) Akropolis (AKRO) Pfizer, Inc. (PFE) Akero Therapeutics, Inc. Common Stock (AKRO) Advanced Micro Devices (AMD) Viking Therapeutics, Inc (VKTX)
Top topics mentioned In the posts about Novo-Nordisk in the last XX hours
stocks healthcare, stocks technology, $novcde, stocks consumer cyclical, eli lilly, investment, stocks financial services, stocks, stocks consumer defensive, $unh, $lly, hims hers, $akro, stocks communication services, stocks bitcoin treasuries, $pfe, akro akero therapeutics inc, advanced micro devices, acquisition, $vktx, $hims, weight loss, $mrk, coins layer 1, $oscr, $amzn, tesla, stocks industrials, $dlo, $pypl, $nvda, costco, catalent inc, $dave, money, momentum, $nbis, johnson johnson, $root, stocks banks, $orcl, $googl, $cost, chapter 11, stocks bitcoin miners, coins solana ecosystem, stockmarket, $52b, $ionq, $mdgl, denmark, $jnj, sarepta therapeutics inc, $ctlt, $qcom, taiwan semiconductor, longterm, novo, $srrk, $uber, cuts, $azn, $lulu, $asml, $hsbc, $abbv, adobe inc, $cnc, stocks crypto treasuries, india, about to, $oklo, targets, $cprt, $srpt, $amd, youtube, $mtsr, $amgn, $meli, $bmy, regeneron pharmaceuticals inc, over the, signals, $tmdx, $ma, stocks basic materials, $elv, coins meme, danish krone, drugs, $asts, employees, sentiment, $nonof, sanofi, stocks energy, asml, $ftnt, $lrcx
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Next obesity battel is South Africa. Wegovy from $NVO was launched in August and $LLY just made a deal with Aspen to distribute Mounjaro Theres some conflicting details if its vials or their KwickPen Mounjaro will be launched with. Seems that top dose for now will be 10mg Both Wegovy and Mounjaro prices is quite low. In the range of $215-315 for top doses. Lower for the start doses. Except UK that's some of the lowest prices i have seen. $VKTX"
X Link @ResearchPulse1 2025-10-15T08:58Z 1473 followers, XXX engagements
"Shifting capital from stocks near their cyclical top to those near their cyclical bottom (or already bottomed out) is always a smart move. I expect a big pullback after the end-of-year rally for these names: $NVDA $AVGO $ORCL $BGM $DUOL (pullback already started) On the other hand these names are worth buying even now: $NVO $PYPL $JD $BABA $UNH"
X Link @MBrooks67658 2025-10-15T07:44Z XXX followers, XX engagements
"Inside Novo Nordisk's 'Club 5000' as Danish staff cuts gain pace REUTERS"
YouTube Link @Reuters 2025-10-15T07:38Z 3.9M followers, XXX engagements
"🌵🐽🐷🎂 You can follow him:@gjm6000. I made several times the profit in just a few days by buying the stocks he recommended. He is worth following. #stock #Index StockPrice🔨 $URBN BearMarket🦦 $COP TechnicalAnalysis🍞 $NVO CandlestickChart🍯 $LINK"
X Link @PilarC38366 2025-10-15T07:35Z X followers, XX engagements